human
bocaviru
hbov
newli
discov
alland
et
al
state
possibl
caus
agent
respiratori
ill
phylogenet
analysi
complet
genom
hbov
reveal
viru
close
relat
canin
minut
viru
bovin
parvoviru
member
bocaviru
genu
parvovirida
famili
hbov
found
respiratori
sampl
investig
worldwid
hbov
may
caus
agent
respiratori
tract
infect
howev
investig
argu
associ
hbov
respiratori
tract
diseas
remain
unproven
high
rate
codetect
hbov
respiratori
pathogen
clinic
epidemiolog
role
respiratori
infect
yet
fulli
elucid
although
recent
found
hbov
could
cultur
differenti
human
airway
epitheli
cell
routin
viral
cultur
hbov
remain
difficult
realtim
pcr
use
estim
viral
load
use
prove
indic
degre
activ
viral
infect
interact
viru
host
role
viral
reactiv
persist
progress
diseas
studi
investig
epidemiolog
hbov
clinic
featur
respiratori
infect
associ
hbov
especi
term
hbov
load
novemb
octob
specimen
patient
randomli
select
among
sampl
collect
patient
refer
korea
univers
guro
hospit
screen
respiratori
virus
among
patient
men
age
patient
rang
day
yr
yr
month
children
age
yr
less
constitut
studi
popul
nasopharyng
aspir
npa
obtain
patient
store
viral
transport
medium
quickli
deliv
laboratori
use
wet
ice
rmix
cultur
system
diagnost
hybrid
athen
oh
usa
use
screen
sampl
presenc
respiratori
virus
influenza
b
virus
parainfluenza
virus
respiratori
syncyti
viru
adenoviru
total
nucleic
acid
extract
sampl
use
instagen
matrix
kit
biorad
hercul
ca
usa
pcr
primer
design
use
beacon
design
softwar
premier
biosoft
intern
palo
alto
ca
usa
conserv
region
code
region
hbov
genom
use
hbov
sequenc
genbank
access
number
forward
primer
revers
primer
target
portion
hbov
gene
convent
pcr
reaction
mixtur
consist
forward
revers
primer
mm
dntp
mm
kcl
mm
u
taq
polymeras
extract
dna
final
volum
pcr
cycl
condit
consist
cycl
involv
reaction
sec
sec
sec
preheat
step
min
pcr
product
obtain
posit
reaction
sequenc
complet
confirm
sequenc
specif
obtain
standard
curv
absolut
quantif
pcr
product
hbov
clone
plasmid
vector
easi
vector
promega
madison
wi
usa
purifi
use
qiaprep
mini
prep
kit
qiagen
inc
valencia
ca
usa
quantifi
use
uv
spectroscopi
genom
serial
dilut
clone
plasmid
prepar
gener
standard
curv
realtim
pcr
viral
load
perform
specimen
posit
hbov
convent
pcr
taqman
probe
label
end
report
molecul
fam
end
black
hole
quencher
biosearch
technolog
inc
novato
ca
usa
assay
perform
use
rotorgen
corbett
life
scienc
sydney
australia
standard
protocol
taqman
univers
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
sampl
reaction
mixtur
contain
forward
revers
primer
extract
dna
amplif
condit
consist
reaction
min
min
cycl
sec
sec
sec
maintain
min
detect
limit
realtim
pcr
hbov
copiesml
correspond
copi
per
reaction
statist
analysi
perform
use
spss
softwar
version
spss
inc
chicago
il
usa
graph
prepar
use
prism
softwar
version
grapad
softwar
inc
san
diego
ca
usa
mannwhitney
u
test
chisquar
fisher
exact
test
perform
assess
signific
p
valu
consid
statist
signific
test
total
sampl
patient
respiratori
symptom
includ
present
studi
ninetythre
sampl
found
posit
hbov
pcr
subsequ
sequenc
respiratori
virus
detect
studi
period
follow
influenza
viru
ifa
patient
influenza
b
viru
ifb
patient
parainfluenza
virus
piv
patient
respiratori
syncyti
viru
rsv
patient
adenoviru
adv
patient
hbov
preval
men
women
hbov
detect
patient
rang
month
yr
month
month
peak
preval
age
month
children
age
yr
less
constitut
hbovposit
patient
tabl
hbov
detect
sampl
obtain
throughout
cours
studi
detect
rate
highest
june
follow
august
may
april
june
hbovposit
case
observ
fig
hbovposit
case
detect
convent
pcr
also
confirm
realtim
pcr
perform
use
taqman
probe
viral
load
detect
hbovposit
sampl
use
realtim
pcr
rang
copiesml
median
copiesml
hbovposit
case
categor
group
lowviralload
group
viral
load
copiesml
highviralload
group
viral
load
copiesml
tabl
hbovposit
patient
age
less
yr
significantli
higher
viral
load
patient
age
yr
respiratori
virus
found
total
hbovposit
sampl
follow
ifa
sampl
ifb
sampl
piv
sampl
rsv
sampl
adv
sampl
case
belong
lowviralload
group
rsv
isol
remain
sampl
hbov
copi
number
copiesml
copiesml
patient
posit
hbov
alon
higher
viral
load
patient
posit
hbov
anoth
respiratori
viru
median
copiesml
vs
copiesml
highviralload
almost
exclus
seen
hbovposit
patient
alon
fig
highviralload
group
significantli
higher
puls
rate
respiratori
rate
correspond
rate
lowviralload
group
respect
tabl
although
durat
hospit
stay
significantli
differ
group
tabl
case
patient
less
day
hospit
stay
highviralload
group
longer
hospit
stay
lowviralload
group
day
vs
day
clinic
characterist
signific
correl
viral
load
hbov
hbovposit
patient
present
cough
sputum
fever
rhinorrhea
crackl
wheez
diarrhea
dyspnea
signific
differ
observ
hbov
viral
load
case
upper
lower
respiratori
tract
infect
twentyon
patient
underli
condit
lowviralload
clinic
examin
hbovposit
patient
show
pneumonia
bronchiol
bronchiti
croup
asthma
sinus
pharyngotonsil
fig
hbov
detect
sampl
obtain
patient
without
pneumonia
respect
respect
howev
signific
differ
observ
viral
load
patient
without
pneumonia
p
ninetythre
nasopharyng
aspir
obtain
patient
agegroup
posit
hbov
detect
rate
similar
state
report
gener
hbov
detect
fewer
respiratori
specimen
howev
higher
detect
rate
rang
report
investig
epidemiolog
associ
respiratori
infect
viral
load
hbovposit
patient
categor
low
highviralload
group
use
copiesml
threshold
valu
detect
rate
hbov
infect
peak
first
year
life
rate
detect
age
month
case
rsv
piv
infect
hbovposit
patient
age
less
yr
belong
highviralload
group
detect
rate
lower
patient
age
yr
patient
belong
exclus
lowviralload
group
hbov
rare
detect
adult
except
case
immunosuppress
lower
detect
rate
viral
load
hbov
older
patient
may
attribut
immun
acquir
infect
younger
age
seroepidemiolog
studi
hbov
show
children
age
yr
seroposit
hbov
lau
et
al
suggest
hbov
infect
might
develop
subsequ
develop
lifelong
immun
confer
neutral
antibodi
produc
respons
infect
frequenc
hbov
codetect
respiratori
virus
hbovposit
sampl
lower
previous
publish
data
differ
codetect
frequenc
attribut
differ
detect
method
molecular
diagnost
method
use
detect
respiratori
virus
studi
wherea
use
viru
cultur
among
hbovposit
patient
also
posit
infect
virus
show
piv
infect
high
associ
hbov
piv
seem
attribut
high
preval
piv
infect
may
interestingli
almost
case
except
two
posit
hbov
anoth
respiratori
viru
belong
lowviralload
group
viru
cultur
use
detect
major
respiratori
virus
isol
viru
could
main
caus
agent
respiratori
ill
therefor
presenc
low
copi
number
hbov
detect
molecular
method
may
indic
prolong
viral
shed
asymptomat
infect
recent
prolong
presenc
hbov
npa
report
result
suggest
singl
hbov
infect
highviralload
group
may
play
activ
role
respiratori
infect
find
consist
norwegian
studi
report
detect
hbov
alon
highviralload
associ
respiratori
tract
infect
studi
patient
highviralload
npa
develop
viremia
frequent
patient
moderateor
lowviralload
studi
hbovposit
patient
highviralload
group
show
significantli
higher
puls
rate
respiratori
rate
lowviralload
group
find
also
support
idea
highviralload
may
associ
respiratori
infect
previou
studi
report
hbov
infect
preval
among
individu
respiratori
virus
studi
perform
hong
kong
higher
detect
rate
hbov
observ
npa
posit
common
respiratori
virus
neg
howev
studi
similar
detect
rate
hbov
observ
sampl
posit
neg
respiratori
virus
rmix
cultur
data
shown
previou
studi
show
case
hbov
infect
found
throughout
year
peak
incid
rate
winter
season
howev
studi
case
hbov
infect
detect
frequent
spring
season
find
similar
report
korea
season
differ
incid
hbov
infect
may
attribut
region
tempor
differ
bastien
et
al
suggest
risk
factor
sever
hbov
infect
appear
similar
rsv
infect
prematur
congenit
heart
diseas
asthma
thirti
percent
hbovposit
patient
underli
condit
heart
diseas
asthma
allergi
preterm
birth
histori
convuls
patient
show
lowviralload
persist
hbov
shed
month
observ
respiratori
fecal
specimen
obtain
patient
signific
underli
diseas
although
find
fulli
understood
postul
result
underli
immunosuppress
summari
hbov
infect
preval
young
children
patient
posit
hbov
alon
mainli
constitut
highviralload
group
hbovposit
patient
infect
caus
respiratori
virus
belong
lowviralload
group
find
suggest
hbov
may
associ
respiratori
infect
